BostonGene Corporation shared a post on X/Twitter:
”We’re excited to announce that our poster, done in collaboration with Jason A. Mouabbi at ASCO24 received the GRASP Advocate Choice Award! The study revealed the intricate heterogeneity of the tumor microenvironment (TME) in invasive lobular carcinoma (ILC) through bulk RNA-seq and spatial biology analyses, highlighting the importance of TME profiling in developing personalized treatments for ILC patients!”
Source: BostonGene Corporation/X